We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900909:SSEShanghai Huayi Group Corporation Ltd. Class B Analysis

Data as of 2026-08-02 - not real-time

$0.51

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shanghai Huayi Group is trading at ¥0.506, comfortably above its 20‑day (¥0.494) and 50‑day (¥0.492) simple moving averages but still below the 200‑day SMA (¥0.522), suggesting short‑term momentum without a long‑term breakout. The 14‑day RSI sits at 62, indicating the stock is in the higher‑than‑average range but not yet overbought, while the MACD histogram is positive and the signal line is bullish, reinforcing a modest upside bias. Volume has been increasing, adding conviction to the technical picture, and the beta of roughly 0.17 points to very low market‑risk sensitivity. On the valuation side, the price‑to‑earnings ratio of 12.6 and price‑to‑book of 0.32 are well below industry norms, and the dividend yield of 3.19% with a 66% payout ratio is supported by strong operating cash flow (¥6.5 bn) and a net cash position (cash ¥16.5 bn vs debt ¥12.6 bn). However, profitability is thin—gross margin 7.5%, operating margin 2.5% and ROE only 1.9%—and revenue growth is modest at 1.6% YoY, flagging limited growth prospects. The DCF‑derived fair value of ¥11.15 versus the current price underscores a deep valuation gap, though the mismatch may reflect currency or unit differences. Overall, the stock appears undervalued from a pure valuation lens, but the low growth and thin margins temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs with bullish MACD
  • RSI in upper‑mid range indicating limited upside
  • Increasing volume supporting current trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (low P/E, low P/B)
  • High dividend yield with sustainable payout
  • Strong net cash position and low beta reducing market risk

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Thin margins and modest revenue growth limit upside
  • Potential regulatory headwinds in the chemicals sector
  • Continued dividend income offsets growth concerns

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin1.22%
P/E Ratio12.7
ROE1.92%
ROA0.03%
Debt/Equity40.58
P/B Ratio0.3
Op. Cash Flow$6.5B
Free Cash Flow$1.4B

Technical Analysis

TrendNeutral
RSI62.2
Support$0.48
Resistance$0.51
MA 20$0.49
MA 50$0.49
MA 200$0.52
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Fair Value$11.15
GradeUndervalued
TypeValue
Dividend Yield3.19%

Risk Assessment

Beta0.17
Volatility17.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.